DK1377280T3 - Fyldmidler som mæthedsfornemmelsesgivende midler - Google Patents

Fyldmidler som mæthedsfornemmelsesgivende midler

Info

Publication number
DK1377280T3
DK1377280T3 DK02725535T DK02725535T DK1377280T3 DK 1377280 T3 DK1377280 T3 DK 1377280T3 DK 02725535 T DK02725535 T DK 02725535T DK 02725535 T DK02725535 T DK 02725535T DK 1377280 T3 DK1377280 T3 DK 1377280T3
Authority
DK
Denmark
Prior art keywords
satiety
fillers
sense
polydextrose
relates
Prior art date
Application number
DK02725535T
Other languages
English (en)
Inventor
Stuart Craig
Philip M Olinger
Tammy Pepper
Original Assignee
Danisco Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23083457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1377280(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Danisco Usa Inc filed Critical Danisco Usa Inc
Application granted granted Critical
Publication of DK1377280T3 publication Critical patent/DK1377280T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/137—Thickening substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/37—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Structures Or Materials For Encapsulating Or Coating Semiconductor Devices Or Solid State Devices (AREA)
  • Dental Preparations (AREA)
DK02725535T 2001-04-09 2002-04-05 Fyldmidler som mæthedsfornemmelsesgivende midler DK1377280T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28286601P 2001-04-09 2001-04-09
PCT/US2002/010749 WO2002080850A2 (en) 2001-04-09 2002-04-05 Bulking agents as satiety agents

Publications (1)

Publication Number Publication Date
DK1377280T3 true DK1377280T3 (da) 2007-10-08

Family

ID=23083457

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02725535T DK1377280T3 (da) 2001-04-09 2002-04-05 Fyldmidler som mæthedsfornemmelsesgivende midler

Country Status (10)

Country Link
US (2) US20030008843A1 (da)
EP (1) EP1377280B1 (da)
JP (1) JP2005508845A (da)
AT (1) ATE367097T1 (da)
AU (1) AU2002256093A1 (da)
DE (1) DE60221234T2 (da)
DK (1) DK1377280T3 (da)
ES (1) ES2290289T3 (da)
PT (1) PT1377280E (da)
WO (1) WO2002080850A2 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8702569D0 (en) * 1987-02-05 1987-03-11 Nat Res Dev Moiety for selective separation
FI20020078A7 (fi) * 2002-01-15 2003-07-16 Danisco Immuunijärjestelmän stimulointi polydextroosilla
US20050003027A1 (en) * 2003-05-09 2005-01-06 Diaz Jose A. Chemical composition and method to bind fat, enhance metabolization, and aid digestion
DE602004022806D1 (de) * 2003-06-04 2009-10-08 Nestec Sa Getränk zur gewichtskontrolle
SE0400257D0 (sv) * 2004-02-09 2004-02-09 Karlshamns Ab New Use and Composition
US20070082104A1 (en) * 2004-08-12 2007-04-12 Sophie De Baets Functional sugar replacement
EP1629730A1 (en) * 2004-08-12 2006-03-01 First-to-Market N.V. Functional sugar replacement
EP1817964A1 (en) * 2006-02-13 2007-08-15 Sweetwell NV Functional sugar replacement
US7736392B2 (en) * 2005-04-28 2010-06-15 Medtronic, Inc. Bulking of upper esophageal sphincter for treatment of obesity
WO2006119355A2 (en) * 2005-05-03 2006-11-09 Albert Einstein College Of Medicine Of Yeshiva University Mammalian hypothalamic nutrient modulation of glucose metabolism
FR2887121B1 (fr) * 2005-06-17 2014-03-21 Gervais Danone Sa Produits laitiers frais a pouvoir satietogene a base de fibres hydrosolubles et procedes de preparation
US20070048356A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial treatment of nonwoven materials for infection control
US20070048358A1 (en) * 2005-08-31 2007-03-01 Schorr Phillip A Antimicrobial substrates
US20070048345A1 (en) * 2005-08-31 2007-03-01 Kimberly-Clark Worldwide, Inc. Antimicrobial composition
US20070048344A1 (en) * 2005-08-31 2007-03-01 Ali Yahiaoui Antimicrobial composition
US8956677B2 (en) * 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
US20070116825A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Confection with High-Potency Sweetener
US20070116800A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Chewing Gum with High-Potency Sweetener
US8435587B2 (en) * 2005-11-23 2013-05-07 The Coca-Cola Company High-potency sweetener composition with long-chain primary aliphatic saturated alcohol and compositions sweetened therewith
US8512789B2 (en) * 2005-11-23 2013-08-20 The Coca-Cola Company High-potency sweetener composition with dietary fiber and compositions sweetened therewith
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US20070116833A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition with Calcium and Compositions Sweetened Therewith
US20070116836A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Osteoporosis and Compositions Sweetened Therewith
US9144251B2 (en) * 2005-11-23 2015-09-29 The Coca-Cola Company High-potency sweetener composition with mineral and compositions sweetened therewith
US8956678B2 (en) * 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with preservative and compositions sweetened therewith
US8524303B2 (en) * 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with phytosterol and compositions sweetened therewith
US20070134391A1 (en) * 2005-11-23 2007-06-14 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Autoimmune Disorders and Compositions Sweetened Therewith
US8377491B2 (en) * 2005-11-23 2013-02-19 The Coca-Cola Company High-potency sweetener composition with vitamin and compositions sweetened therewith
US20070116831A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Dental Composition with High-Potency Sweetener
US8993027B2 (en) * 2005-11-23 2015-03-31 The Coca-Cola Company Natural high-potency tabletop sweetener compositions with improved temporal and/or flavor profile, methods for their formulation, and uses
US20070116822A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-potency sweetener composition with saponin and compositions sweetened therewith
US20070116839A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition With C-Reactive Protein Reducing Substance and Compositions Sweetened Therewith
KR20080071606A (ko) * 2005-11-23 2008-08-04 더 코카콜라 컴파니 시간 특성 및/또는 향미 특성이 개선된 인공 감미료조성물과 이들의 제제 방법 및 용도
US20070116829A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Pharmaceutical Composition with High-Potency Sweetener
US9101161B2 (en) * 2006-11-02 2015-08-11 The Coca-Cola Company High-potency sweetener composition with phytoestrogen and compositions sweetened therewith
US20080107787A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company Anti-Diabetic Composition with High-Potency Sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
WO2008094434A2 (en) * 2007-01-26 2008-08-07 Archer-Daniels-Midland Company Compositions comprising wheat protein isolate and related methods
DE102007009029A1 (de) * 2007-02-23 2008-09-04 Südzucker AG Mannheim/Ochsenfurt Niedrig-glykämische Mischungen
JP5535456B2 (ja) * 2008-07-09 2014-07-02 松谷化学工業株式会社 食物繊維と希少糖を含む生体機能改善組成物。
AU2010282710B2 (en) * 2009-08-13 2015-01-15 Kellanova Low water activity food binder and methods related thereto
JP5570244B2 (ja) * 2010-02-23 2014-08-13 株式会社ヤクルト本社 腸間膜脂肪低減剤
US20150296851A1 (en) * 2012-11-27 2015-10-22 Shanghai Jiao Tong University Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof
CN108601383B (zh) * 2016-03-09 2022-08-12 Cj第一制糖株式会社 具有耐酸性增加的寡糖的甜味剂、包含所述甜味剂的食物组成物以及增加寡糖耐酸性的方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2436967A (en) * 1942-04-01 1948-03-02 Corn Prod Refining Co Polymerization of sugars
US2719179A (en) * 1951-01-25 1955-09-27 Mora Peter Tibor Branched-chain carbohydrate polymers and their preparation
US3766165A (en) * 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
US3843786A (en) * 1973-11-05 1974-10-22 Purex Corp Method of controlling human appetite
US4882159A (en) * 1985-12-20 1989-11-21 Warner Lambert Co. Confectionery delivery system for appetite suppressants
US5013722A (en) * 1986-06-06 1991-05-07 Hoffmann-Laroche Inc. Cholecystokinin analogs for controlling appetite
US4808701A (en) * 1987-03-30 1989-02-28 Hoffmann-La Roche Inc. Cyclic peptides having appetite regulating activity
US5422346A (en) * 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
US4965354A (en) * 1988-02-26 1990-10-23 Taito Company, Ltd. Process for producing a condensed polysaccharide
US5445826A (en) * 1988-06-28 1995-08-29 Cibus Pharmaceutical, Inc. Delivery system containing a gel-forming dietary fiber and a drug
US5098730A (en) * 1988-11-14 1992-03-24 Cultor Ltd. Dietetic sweetening composition
US5667593A (en) * 1989-01-26 1997-09-16 Cultor Ltd. Modified polydextrose and process therefor
US5051500A (en) * 1989-08-11 1991-09-24 A. E. Staley Manufacturing Company Method of preparing a randomly-bonded polysaccharide
US5378491A (en) * 1990-02-20 1995-01-03 A. E. Staley Manufacturing Co. Method of preparing a starch hydrolysate, an aqueous starch hydrolysate dispersion, method of preparing a food containing a starch hydrolysate, and a food formulation containing a starch hydrolysate
SE466130B (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande dietfiberkomposition
EP0572424B1 (en) * 1991-02-20 1996-11-20 Pfizer Inc. Reduced polydextrose
US5336486A (en) * 1991-03-28 1994-08-09 Theratech, Inc. Appetite control method
FR2688800B1 (fr) * 1992-03-19 1995-06-16 Roquette Freres Procede de preparation de polysaccharides peu digestibles, eventuellement hydrogenes.
US5273754A (en) * 1992-03-27 1993-12-28 Mann Morris A Appetite suppressant composition and method relating thereto
US5322697A (en) * 1992-05-28 1994-06-21 Meyer James H Composition and method for inducing satiety
FR2697023B1 (fr) * 1992-10-16 1994-12-30 Roquette Freres Polymère soluble hypocalorique du glucose et procédé de préparation de ce polymère .
US5728225A (en) * 1993-07-26 1998-03-17 Roquette Freres Viscous liquid compositions of xylitol and a process for preparing them
FR2712891B1 (fr) * 1993-11-22 1996-02-02 Roquette Freres Procédé de purification d'un polymère soluble hypocalorique du glucose et produit ainsi obtenu.
US5550113A (en) * 1994-07-20 1996-08-27 Mann; Morris A. Blood sugar regulating composition and methods relating thereto
FR2726829B1 (fr) * 1994-11-10 1997-01-17 Roquette Freres Composition de polyols, son procede de preparation et ses applications
EP0749697A1 (en) * 1995-06-22 1996-12-27 Hercules Incorporated Coated food
FR2766709B1 (fr) * 1997-07-31 2000-04-07 Dominique Cingotti Procede pour la preparation d'un extrait de principes actifs sous forme de microgranules a base de fibres alimentaires entierement solubles destines a differentes formes galeniques
JP2779616B1 (ja) * 1997-09-10 1998-07-23 株式会社紀文フードケミファ 食物繊維含有組成物
US6207699B1 (en) * 1999-06-18 2001-03-27 Richard Brian Rothman Pharmaceutical combinations for treating obesity and food craving
US6534487B1 (en) * 1999-08-03 2003-03-18 Childrens Hospital Los Angeles Methods for suppressing appetite and enhancing exercise and recovery
DE29915656U1 (de) * 1999-09-06 2000-04-20 Beisel, Günther, 40789 Monheim Vernetztes Mittel zur Erzeugung eines langanhaltenden Sättigungseffekts
AUPQ673300A0 (en) * 2000-04-06 2000-05-04 Penford Australia Limited Starch sub-types and lipid metabolism
DE10037165A1 (de) * 2000-07-20 2002-02-21 Inst Angewandte Chemie Berlin Katalysator für die Entfernung von Kohlenwasserstoffspuren aus Gasströmen
FI20020078A7 (fi) * 2002-01-15 2003-07-16 Danisco Immuunijärjestelmän stimulointi polydextroosilla
FI119429B (fi) * 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset

Also Published As

Publication number Publication date
EP1377280A2 (en) 2004-01-07
DE60221234D1 (de) 2007-08-30
WO2002080850A3 (en) 2003-03-13
EP1377280A4 (en) 2004-07-07
ATE367097T1 (de) 2007-08-15
DE60221234T2 (de) 2008-05-21
AU2002256093A1 (en) 2002-10-21
WO2002080850A2 (en) 2002-10-17
ES2290289T3 (es) 2008-02-16
US20050037993A1 (en) 2005-02-17
PT1377280E (pt) 2007-10-24
JP2005508845A (ja) 2005-04-07
EP1377280B1 (en) 2007-07-18
US20030008843A1 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
DK1377280T3 (da) Fyldmidler som mæthedsfornemmelsesgivende midler
PL374700A1 (pl) Zastosowanie inhibitorów syntezy cytokiny do leczenia zespołu suchego oka
ATE510534T1 (de) Naltrexonhydrochlorid-zusammensetzungen
ATE465712T1 (de) Ultrafeine zusammensetzungen von formoterol
CY1112487T1 (el) Βραχειας-δρασης ηρεμιστικοι υπνωτικοι παραγοντες για αναισθησια και καταστολη
IL166433A0 (en) Vaccine compositions comprising l2 and/or l3 immunotype lipoligosaccharides from lgtb neisseria minigitidis
EP1843776A4 (en) PURIFIED AMPHILIC PEPTIDE COMPOSITIONS AND ITS USE
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
DK1501815T3 (da) Substituerede phenylacetamider og anvendelse deraf som glucokinaseaktivatorer
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
DE60310542D1 (de) Kühlende zusammensetzungen und deren verwendungen
NO20054711D0 (no) Fremgangsmater og farmasoytiske blandinger for palitelig oppnaelse av akseptable serum-testosteronnivaer
NO20043441L (no) Orodispersibel farmasoytisk sammensetning omfattende agomelatin
FI20021660A0 (fi) Hiilihydraattien uusi käyttö ja koostumukset
IL184266A (en) Benzazole analogues, preparations containing them and their use as inhibitors of protein kinase
NO20060328L (no) Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser
DE60316636D1 (de) Mittels Additionsreaktion härtbare Organopolysiloxan-Zusammensetzungen
PA8571901A1 (es) Nueva composicion farmaceutica
DK2465493T3 (da) Topiske sammensætninger til forebyggelsen og behandlingen af irritation af mukøse celler
SM200300009B (it) Composizione e suo uso terapeutico
TW200730190A (en) New combination to treat liver fibrosis
EP1773363A4 (en) NGNA COMPOSITIONS AND APPLICATION PROCEDURES
AP2005003294A0 (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
WO2007022321A3 (en) Substituted indoles and use thereof